The structure of Oxymorphone
Find information on thousands of medical conditions and prescription drugs.

Oxymorphone

Oxymorphone is a powerful synthetic narcotic analgesic drug that is similar to morphine. Clinically, it is administered either via injection or suppository, typically in dosages of 1mg (injected) to 5mg (suppository). As a narcotic, oxymorphone can be habit forming, leading to addiction. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
Methoxsalen
OCL
Octabenzone
Octanoic acid
Octopamine
Octreotide
Ofloxacin
Ofloxacin
Olanzapine
Omeprazole
Oncovin
Ondansetron
Opium
Oratane
Oretic
Orinase
Orlistat
Ornidazole
Ornithine
Orotic acid
Orphenadrine
Ortho Evra
Oruvail
Ovcon
Ovral
Ovrette
Oxaliplatin
Oxamniquine
Oxandrin
Oxandrolone
Oxaprozin
Oxazepam
Oxcarbazepine
Oxetine
Oxibendazole
Oxiracetam
Oxprenolol
Oxybenzone
Oxybuprocaine
Oxycodone
Oxycodone
Oxymetazoline
Oxymetholone
Oxymorphone
Oxytetracycline
Oxytocin
P
Q
R
S
T
U
V
W
X
Y
Z

Chemical Structure

The chemical structure of Oxymorphone could be also described as 14-Hydroxydihydromorphinone.

Usage

In some cases, it is used during pregnancy. Some veterinarians use the drug during animal operations, such as spaying and neutering or declawing.

A semi-synthetic phenanthrene narcotic agonist, oxymorphone HCL occurs as odorless white crystals or white to off-white powder. It will darken in color with prolonged exposure to light. One gram of oxymorphone is soluble in 4ml of water and it is slightly soluble in alcohol and ether. The commercially available injection has a pH of 2.7-4.5.

Legal Status

Oxymorphone is a C-II controlled substance.

Medicaments

Injectable opioid sedative/restraining agent, analgesic and preanesthetic

DuPont markets oxymorphone under the trade name Numorphan.

Read more at Wikipedia.org


[List your site here Free!]


Endo Pharmaceuticals - Generics Notebook - oxymorphone ER, oxymorphone IR - Brief Article
From Drug Store News, 11/17/03

Endo Pharmaceuticals received approvable letters for both oxymorphone extended-release tablets (oxymorphone ER) and immediate-release tablets (oxymorphone IR).

In the letters, the FDA requested that Endo provide additional clinical trials to confirm the safety and efficacy of the products.

We remain confident that these products are safe and efficacious and will complement the already marketed injectable and suppository forms of oxymorphone, stated Carol Ammon, Endo chairman and chief executive officer.

COPYRIGHT 2003 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2003 Gale Group

Return to Oxymorphone
Home Contact Resources Exchange Links ebay